moderate, severe Perennial Allergic Rhinitis (PAR)
moderate, severe Perennial Allergic Rhinitis (PAR) is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.
- Indicated drugs
What you can answer from here — as of November 01, 2026
1Indicated drugWith each drug's targets and mechanismListed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not proseSign in
Which approved drugs for moderate, severe Perennial Allergic Rhinitis (PAR) share a target, and which companies have late-stage candidates against it?
Create a free account or log in to explore the full data card.
Create Account